María José
Larráyoz Ilundáin
Clínico Asociado
Harvard Medical School
Boston, Estados UnidosHarvard Medical School-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2023
-
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma
Nature Medicine, Vol. 29, Núm. 3, pp. 632-645